Instil Bio Inc expected to post a loss of $2.11 a share - Earnings Preview

Instil Bio

08/11/2024 15:51

* Instil Bio Inc  TIL.OQ   TIL.O  is expected to show a rise
in
quarterly revenue when it reports  results on November 11
(estimated) for the period ending September 30 2024
    * The Dallas Texas-based  company is expected to report
revenue of
$950 thousand, according to the mean estimate from 4 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Instil Bio Inc is for a
loss
of $2.11 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Instil Bio
Inc is
120.00​, above​ its last closing price of $28.44. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -2.99       -2.98      -2.29     Beat    23.2
 Mar. 31 2024  -2.22       -2.23      -3.74     Missed  -67.7
 Dec. 31 2023  -2.29       -2.84      -1.99     Beat    30.1​
 Sep. 30 2023  -1.98       -2.00      -10.40    Missed  -420
 ​​Jun.        -3.47       -3.27      -2.80     Beat    14.3
 30 2023                                                
 Mar. 31 2023  -3.09       -3.10      -8.80     Missed  -183.9
                                                        ​
 Dec. 31 2022  -8.00       -8.27      -4.80     Beat    41.9
 Sep. 30 2022  -8.99       -8.72      -8.60     Beat    1.4
 This summary was machine generated November 8 at 15:50 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)